Psychemedics Corporation Financial Ratios — PMD Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	23.37	27.3	21.34	24.81	15.78	6.55	28.38	23.75	17.81	5.87	-14.98	-2.92	-5.38	-26.75	-18.03
Return on Capital (%)	-32.61	-46.72	-42.16	-55.61	-94.05	- -	-346.44	-5,188.99	570.94	119.67	- -	- -	- -	- -	- -
Return on Invested Capital (%)	27.31	33.82	27.12	32.24	20.86	- -	36.83	28.91	20.75	6.84	- -	- -	- -	- -	- -
Gross Margin (%)	59.88	60.08	56.5	57.29	51.83	47.14	55.03	49.93	48.32	43.64	22.87	41.21	36.81	38.07	36.07
EBITDA Margin (%)	23.37	25.61	21.89	24.48	19.65	11.87	31.82	27.62	25.01	15.69	-11.42	15.65	8.85	-1.14	0.96
Operating Margin (%)	21.95	24.08	19.57	21.24	16.06	5.45	25.94	20.55	17.83	7.96	-28.4	0.84	-4.29	-13.22	-9.62
Incremental Operating Margin (%)	58.03	34.82	-76.26	46.8	-43.53	144.35	71.96	-270.5	-18.41	92.31	- -	176.81	- -	- -	- -
Pretax Margin (%)	22.07	24.1	19.58	21.58	15.86	4.99	25.59	20.6	17.93	8.11	-29.05	-3.3	-4.12	-15.56	-9.73
Profit Margin (%)	13	14.48	11.81	14.16	10.98	5.6	17.13	15.42	10.74	4.09	-18.07	-2.67	-4.29	-18.8	-9.45
Net Income to Common Margin (%)	13	14.48	11.81	14.16	10.98	5.6	17.13	15.42	10.74	4.09	-18.07	-2.67	-4.29	-18.8	-9.45
Effective Tax Rate (%)	41.1	39.9	39.65	34.38	30.8	- -	33.06	25.14	40.1	49.54	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	95.66	71.96	105.94	83.54	100.19	214.49	48.92	53.73	82.83	257.46	-25.73	-41.95	-109.41	-19.23	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	- -	- -	- -	6	6	3	3	2	6	9	5	4	2	1
ST Debt	- -	- -	- -	- -	1	2	1	1	- -	2	2	2	1	1	1
LT Debt	- -	- -	- -	- -	5	4	2	2	1	4	7	3	2	1	- -
Total Debt/EBITDA	- -	- -	- -	- -	1.09	1.84	0.27	0.31	0.15	1.01	-3.65	1.31	1.6	-9.16	6.2
Net Debt/EBITDA	-0.79	-0.9	-0.56	-0.6	0.46	1	-0.04	-0.44	-0.23	-0.79	-0.53	-0.19	-1.86	6.61	-6.43
Total Debt/EBIT	- -	- -	- -	- -	1.33	4.01	0.33	0.41	0.21	1.99	-1.47	24.53	-3.3	-0.79	-0.62
Net Debt/EBIT	-0.84	-0.96	-0.62	-0.7	0.56	2.18	-0.06	-0.59	-0.32	-1.55	-0.21	-3.49	3.83	0.57	0.64
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	92.57	152.28	100.69	- -	- -	- -	- -	-14.76	7.23
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	77.55	135.65	89.45	- -	- -	- -	- -	-24	3.88
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	75.45	113.29	71.79	- -	- -	- -	- -	-171.82	-72.81
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-67.63	-50.57	-50.68	-39.46	-27.14	-37.51	-19.63	-7.85	-5.19	-13.52	-35.72	-44.17	-62.93	-135.82	-223.62
Long-Term Debt/Equity (%)	- -	- -	- -	- -	37.77	36.59	14.33	13	6.47	25.72	58.66	28.42	20.82	14.16	9.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1,685.76	-179.95	-145.92	186.87	363.96	192.78	2,244.34	-79.21	-27.31	-6.54	-2.74
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	20.14	19.39	8.94	9.13	4.85	15.71	30.58	16.14	11.97	7.67	5.73
Total Debt/Equity (%)	- -	- -	- -	- -	48.67	50.47	21.66	18.14	8.68	35.48	71.15	41.88	33.18	34.44	22.73
Total Debt/Capital (%)	- -	- -	- -	- -	-2,172.53	-248.19	-220.55	260.77	488.89	265.91	2,722.32	-116.73	-43.51	-15.91	-6.69
Total Debt/Total Assets (%)	- -	- -	- -	- -	25.95	26.74	13.51	12.74	6.52	21.67	37.09	23.79	19.08	18.64	14.02
Net Debt to Equity	-38.17	-50.43	-27.32	-32.34	20.53	27.44	-3.57	-25.71	-13.02	-27.67	10.38	-5.95	-38.54	-24.87	-23.55
Net Debt/Capital (%)	31.86	44.36	29.99	37.81	-67.59	-63.26	10.18	69.69	65.34	92.36	-51.84	11.42	32.02	10.11	6.41
EBITDA	5	6	6	7	6	3	12	11	11	6	-2	4	2	- -	- -
EBITDA-CapEx	4	5	3	5	-2	1	10	10	9	4	-3	4	2	- -	- -
Operating Income (Loss)	4	6	5	6	5	1	10	8	8	3	-6	- -	-1	-3	-2

Liquidity (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	2.84	2.44	1.47	1.34	1	0.75	0.88	1.93	1.96	1.25	0.72	0.34	0.83	0.42	0.52
Current Ratio	5.24	5.04	4.6	3.37	2.94	2.28	2.41	3.28	3.42	2.2	2.44	1.76	1.74	1.45	1.82
Quick Ratio	4.78	4.65	4.1	3.01	2.64	1.98	2.17	2.99	3.15	1.98	2.2	1.51	1.54	1.2	1.45
CFO/Avg Current Liab	1.98	1.83	1.41	2.36	1.36	1.28	2.3	2.1	1.91	0.87	-0.84	0.08	0.85	-0.28	0.25
Common Equity/Total Assets	-67.63	-50.57	-50.68	-39.46	-27.14	-37.51	-19.63	-7.85	-5.19	-13.52	-35.72	-44.17	-62.93	-135.82	-223.62
Long-Term Debt/Equity (%)	- -	- -	- -	- -	37.77	36.59	14.33	13	6.47	25.72	58.66	28.42	20.82	14.16	9.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-1,685.76	-179.95	-145.92	186.87	363.96	192.78	2,244.34	-79.21	-27.31	-6.54	-2.74
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	20.14	19.39	8.94	9.13	4.85	15.71	30.58	16.14	11.97	7.67	5.73
Total Debt/Equity (%)	- -	- -	- -	- -	48.67	50.47	21.66	18.14	8.68	35.48	71.15	41.88	33.18	34.44	22.73
Total Debt/Capital (%)	- -	- -	- -	- -	-2,172.53	-248.19	-220.55	260.77	488.89	265.91	2,722.32	-116.73	-43.51	-15.91	-6.69
Total Debt/Total Assets (%)	- -	- -	- -	- -	25.95	26.74	13.51	12.74	6.52	21.67	37.09	23.79	19.08	18.64	14.02
CFO/Total Liabilities	163.23	142.26	106.51	139.29	39.64	44.2	98.34	115.95	127.33	40.23	-35.53	4.45	61.42	-26.18	29.14
CFO/CapEx	4.03	2.9	1.39	3.89	0.59	2.61	4.61	7.64	6.66	2.57	-4.12	2.27	26.15	-9.43	10.68
Altman's Z-Score	10.69	9.91	10.89	10.58	5.06	3.65	9.89	10.03	10.41	4.47	1.23	3.23	2.62	1.11	-1.2

Working Capital (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	5.81	5.74	5.54	5.98	6.91	7.08	8.31	7.69	9.16	8.75	5.99	6.67	6.43	5.95	6.36
Days Sales Outstanding	62.82	63.61	65.93	61.06	52.78	51.53	43.9	47.46	39.85	41.7	60.97	54.74	56.8	61.33	57.36
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	18.32	11.58	13.45	19.45	20.75	17.91	16.62	22.58	40.84	32.69	27.59	18.64	22.12	22.81	20.73
Accounts Payable Turnover Days	19.92	31.53	27.14	18.77	17.59	20.38	21.97	16.17	8.94	11.16	13.23	19.58	16.5	16	17.61
Cash Conversion Cycle	42.9	32.08	38.79	42.29	35.2	31.16	21.93	31.29	30.91	30.53	47.74	35.17	40.3	45.33	39.75
Inventory to Cash Days	62.82	63.61	65.93	61.06	52.78	51.53	43.9	47.46	39.85	41.7	60.97	54.74	56.8	61.33	57.36
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	26	31	39	56	61	43	109	95	76	47	27	37	27	17	- -
- Cash & Cash Equivalents	4	6	3	4	4	3	4	8	4	7	3	2	5	2	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	6	6	3	3	2	6	9	5	4	2	1
Enterprise Value	21	25	36	52	63	46	109	90	69	46	33	41	26	17	- -
Total Capital	-8	-7	-7	-7	- -	-2	-2	1	- -	2	- -	-4	-8	-14	-17
Total Debt/Capital (%)	- -	- -	- -	- -	-2,172.53	-248.19	-220.55	260.77	488.89	265.91	2,722.32	-116.73	-43.51	-15.91	-6.69
Total Debt / EV	- -	- -	- -	- -	0.1	0.13	0.03	0.04	0.02	0.13	0.27	0.13	0.14	0.13	-4.65
EV/Sales	1.02	1.05	1.42	1.94	2.17	1.71	2.79	2.26	1.63	1.21	1.53	1.63	1.04	0.78	- -
EV/EBITDA	4.38	4.1	6.47	7.91	11.03	14.39	8.78	8.18	6.5	7.71	- -	10.41	11.78	- -	- -
EV/EBIT	4.66	4.36	7.24	9.12	13.5	31.32	10.77	11	9.12	15.2	- -	194.14	- -	- -	- -
EV/Cash Flow to Firm	6.24	6.42	11.57	8.74	14.21	10.06	11.63	9.75	8.68	10.58	- -	98.01	5.38	- -	- -
EV/Free Cash Flow to Firm	5	4.77	6.74	6.95	5.27	7.28	9.58	8.63	7.56	7.61	- -	68.08	5.18	- -	- -
Diluted Market Cap	26	31	39	56	61	43	110	96	76	47	27	37	28	17	- -
Diluted Enterprise Value	23	25	36	52	64	46	109	91	74	46	33	41	26	17	- -
EV per Share	3.95	4.83	6.79	9.82	11.82	8.53	19.94	16.34	12.6	8.26	5.92	7.26	4.63	3.02	- -
TTM Sales	20	24	25	27	29	27	39	40	43	38	21	25	25	22	20
TTM EBITDA	5	6	6	7	6	3	12	11	11	6	-2	4	2	- -	- -
TTM Operating Income	4	6	5	6	5	1	10	8	8	3	-6	- -	-1	-3	-2
TTM Cash Flow to Firm	3	4	3	6	4	5	9	9	8	4	-4	- -	5	-1	1
TTM Free Cash Flow to Firm	4	5	5	7	12	6	11	10	9	6	-3	1	5	-1	1

Multiples (USD)

API ChatGPT

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	6.42	5.83	7.33	7.5	5.07	6.78	9.73	9.26	8.33	7.83	-8.64	62.82	5.44	-12.84	- -
EV/EBIT	4.66	4.36	7.24	9.12	13.5	31.32	10.77	11	9.12	15.2	- -	194.14	- -	- -	- -
Enterprise Value	21	25	36	52	63	46	109	90	69	46	33	41	26	17	- -
Low Price	6.89	6.85	9.11	10.55	12.42	9.5	7.76	13.81	13.94	7.12	3.58	4.95	4.85	2.06	1.11
EV/Sales	1.02	1.05	1.42	1.94	2.17	1.71	2.79	2.26	1.63	1.21	1.53	1.63	1.04	0.78	- -
EV/EBITDA	4.38	4.1	6.47	7.91	11.03	14.39	8.78	8.18	6.5	7.71	- -	10.41	11.78	- -	- -
Price/Earnings	10.06	8.84	13.01	14.71	18.93	28.38	16.39	15.44	16.52	30.41	- -	- -	- -	- -	- -
Price/Earnings Average	10	8.56	12.47	12.07	18.5	36.56	10.9	15.44	19.96	36.64	-7.83	-57.73	-32.61	-6.09	- -
Price/Earnings High	19.82	16.67	22.05	20.75	31.34	63.78	21.26	25.11	27.49	70.27	-15.34	-74.8	-40.72	-9.33	- -
Price/Earnings Low	13.73	10.27	16.08	14.69	20.75	33.98	6.34	12.39	16.75	25.48	-5.14	-41.6	-25.42	-2.85	- -
Price/Book Value	-3.3	-4.42	-5.42	-8.57	-9.28	-5.19	-22.27	-45.4	-58.48	-12.6	-3.11	-3.93	-2.33	-1.01	- -
Price/Book Value Average	-3.29	-4.28	-5.19	-7.04	-9.08	-6.68	-14.82	-45.4	-70.65	-15.17	-3.52	-4.03	-3	-1.51	- -
Price/Book Value High	-6.51	-8.33	-9.18	-12.09	-15.37	-11.66	-28.89	-73.83	-97.3	-29.1	-6.9	-5.23	-3.74	-2.31	- -
Price/Book Value Low	-4.51	-5.13	-6.7	-8.56	-10.18	-6.21	-8.62	-36.43	-59.28	-10.55	-2.31	-2.91	-2.34	-0.71	- -
Price/Tangible Book Value	2.7	2.8	3.46	4.56	4.73	3.67	7.01	5.08	4.04	2.79	2.13	3.06	2.55	2.55	- -
Price/Tangible Book Value Average	2.68	2.71	3.31	3.74	4.62	4.73	4.66	5.08	4.88	3.36	2.42	3.14	3.28	3.79	- -
Price/Tangible Book Value High	5.32	5.27	5.85	6.43	7.83	8.26	9.1	8.26	6.72	6.44	4.73	4.06	4.1	5.81	- -
Price/Tangible Book Value Low	3.68	3.25	4.27	4.55	5.18	4.4	2.71	4.07	4.09	2.34	1.58	2.26	2.56	1.77	- -
Price/Sales	1.31	1.28	1.54	2.08	2.08	1.59	2.81	2.38	1.77	1.24	1.25	1.5	1.09	0.77	- -
Price/Sales Average	1.3	1.24	1.47	1.71	2.03	2.05	1.87	2.38	2.14	1.5	1.42	1.54	1.4	1.14	- -
Price/Sales High	2.58	2.41	2.6	2.94	3.44	3.57	3.64	3.87	2.95	2.88	2.77	2	1.75	1.75	- -
Price/Sales Low	1.78	1.49	1.9	2.08	2.28	1.9	1.09	1.91	1.8	1.04	0.93	1.11	1.09	0.54	- -
Price/Cash Flow	7.98	7.84	12.56	9.41	13.62	9.36	11.81	10.33	9.55	10.88	-6.54	90.44	5.62	-11.48	- -
Price/Cash Flow Average	7.94	7.59	12.04	7.72	13.31	12.06	7.85	10.33	11.54	13.11	-7.4	92.73	7.23	-17.09	- -
Price/Cash Flow High	15.72	14.78	21.29	13.27	22.55	21.04	15.32	16.81	15.89	25.15	-14.5	120.15	9.03	-26.18	- -
Price/Cash Flow Low	10.89	9.1	15.53	9.39	14.93	11.21	4.57	8.29	9.68	9.12	-4.85	66.82	5.63	-7.99	- -
Price/Free Cash Flow Average	6.38	5.65	7.03	6.16	4.95	8.74	6.47	9.26	10.06	9.44	-9.78	64.41	6.99	-19.12	- -
Price/Free Cash Flow High	12.64	11	12.42	10.58	8.39	15.24	12.62	15.06	13.86	18.1	-19.14	83.46	8.73	-29.29	- -
Price/Free Cash Flow Low	8.75	6.77	9.06	7.49	5.56	8.12	3.77	7.43	8.44	6.56	-6.41	46.42	5.45	-8.94	- -
EV/Sales Average	1.12	1.01	1.35	1.56	2.12	2.17	1.85	2.26	2.09	1.46	1.7	1.67	1.35	1.16	- -
EV/Sales High	2.39	2.18	2.48	2.79	3.53	3.69	3.63	3.75	2.9	2.84	3.06	2.12	1.7	1.77	- -
EV/Sales Low	1.6	1.26	1.78	1.93	2.37	2.02	1.07	1.79	1.74	1.01	1.21	1.24	1.05	0.55	- -
EV/EBITDA Average	4.77	3.94	6.17	6.38	10.8	18.25	5.82	8.18	8.34	9.33	-14.87	10.65	15.31	-102.13	-1.34
EV/EBITDA High	10.23	8.52	11.34	11.4	17.97	31.1	11.4	13.58	11.58	18.11	-26.75	13.56	19.24	-155.69	-1.34
EV/EBITDA Low	6.84	4.9	8.12	7.89	12.05	17.04	3.37	6.48	6.96	6.42	-10.61	7.9	11.81	-48.44	-1.34
EV/EBIT Average	5.08	4.19	6.91	7.35	13.21	39.73	7.15	11	11.7	18.4	-5.98	198.69	-31.56	-8.78	0.13
EV/EBIT High	10.89	9.07	12.69	13.14	21.98	67.69	13.99	18.26	16.24	35.7	-10.76	253	-39.67	-13.38	0.13
EV/EBIT Low	7.28	5.22	9.09	9.1	14.74	37.08	4.14	8.71	9.77	12.66	-4.27	147.37	-24.36	-4.16	0.13
Last Price	5.05	5.9	7.37	10.57	11.33	7.93	20.04	17.21	13.75	8.5	4.82	6.7	4.84	2.96	2.24
High Price	9.95	11.12	12.49	14.9	18.76	17.83	26	27.99	22.88	19.64	10.69	8.9	7.77	6.75	3.93
Enterprise Value Average	22	24	34	42	62	58	72	90	89	55	36	42	34	26	- -
Enterprise Value High	48	53	63	75	103	100	141	149	124	107	65	53	43	39	- -
Enterprise Value Low	32	30	45	52	69	55	42	71	74	38	26	31	26	12	- -

Shares Outstanding	5	5	5	5	5	5	5	5	6	6	6	6	6	6	6
Diluted Weighted Avg Shares	5	5	5	5	5	5	5	6	6	6	6	6	6	6	- -
Basic Weighted Avg Shares	5	5	5	5	5	5	5	5	6	6	6	6	6	6	- -
Revenue per Share	3.86	4.61	4.8	5.07	5.45	4.99	7.14	7.23	7.75	6.83	3.86	4.46	4.44	3.85	- -
EBITDA per Share	0.9	1.18	1.05	1.24	1.07	0.59	2.27	2	1.94	1.07	-0.44	0.7	0.39	-0.04	- -
Operating Income per Share	0.85	1.11	0.94	1.08	0.88	0.27	1.85	1.49	1.38	0.54	-1.1	0.04	-0.19	-0.51	- -
Basic EPS, GAAP	0.5	0.67	0.57	0.72	0.6	0.28	1.22	1.11	0.83	0.28	-0.7	-0.12	-0.19	-0.72	- -
Basic EPS from Cont Ops	0.5	0.67	0.57	0.72	0.6	0.28	1.22	1.11	0.83	0.28	-0.7	-0.12	-0.19	-0.72	- -
Diluted EPS, GAAP	0.5	0.67	0.57	0.72	0.6	0.28	1.22	1.1	0.83	0.28	-0.7	-0.12	-0.19	-0.72	- -
Diluted EPS from Cont Ops	0.5	0.67	0.57	0.72	0.6	0.28	1.22	1.1	0.83	0.28	-0.7	-0.12	-0.19	-0.72	- -
Dividend per Share	0.48	0.48	0.6	0.6	0.6	0.6	0.6	0.6	0.69	0.72	0.18	0.05	0.21	0.14	- -
Cash Flow per Share	0.63	0.75	0.59	1.12	0.83	0.85	1.7	1.67	1.44	0.78	-0.74	0.07	0.86	-0.26	- -
Free Cash Flow per Basic Share	0.48	0.49	0.17	0.83	-0.58	0.52	1.33	1.45	1.22	0.48	-0.92	0.04	0.83	-0.29	- -
Cash & Equivalents per Share	1.1	1.06	0.58	0.75	0.67	0.5	0.72	1.49	1.45	1.32	0.51	0.36	0.84	0.34	- -
Book Value per Share	-1.53	-1.33	-1.36	-1.23	-1.22	-1.53	-0.9	-0.38	-0.24	-0.67	-1.55	-1.7	-2.07	-2.92	- -
Tangible Book Value per Share	1.87	2.11	2.13	2.32	2.4	2.16	2.86	3.39	3.4	3.05	2.26	2.19	1.9	1.16	- -

Psychemedics Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)